Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
1.170
+0.070 (6.36%)
Apr 1, 2025, 9:30 AM EST - Market open

Theriva Biologics Market Cap

Theriva Biologics has a market cap or net worth of $3.12 million as of April 1, 2025. Its market cap has decreased by -55.48% in one year.

Market Cap
3.12M
Enterprise Value
-6.93M
1-Year Change
-55.48%
Ranking
Category
Stock Price
$1.17

Market Cap Chart

Since April 2, 2007, Theriva Biologics's market cap has decreased from $81.60M to $3.12M, a decrease of -96.18%. That is a compound annual growth rate of -16.58%.

History

DateMarket Cap% Change
Mar 31, 20253.10M-36.73%
Dec 31, 20244.90M-32.88%
Dec 29, 20237.30M1.39%
Dec 30, 20227.20M-79.94%
Dec 31, 202135.90M366.23%
Dec 31, 20207.70M-9.41%
Dec 31, 20198.50M11.84%
Dec 31, 20187.60M-88.36%
Dec 29, 201765.30M-7.11%
Dec 30, 201670.30M-66.19%
Dec 31, 2015207.90M96.32%
Dec 31, 2014105.90M55.05%
Dec 31, 201368.30M-11.18%
Dec 31, 201276.90M116.62%
Dec 30, 201135.50M22.84%
Dec 31, 201028.90M140.83%
Dec 31, 200912.00M224.32%
Dec 31, 20083.70M-96.22%
Dec 31, 200797.80M19.85%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings